PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...

French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

In the French government issued a stern warning to Clayton, Dubilier & Rice (CD&R), an American private equity firm, ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand said on Sunday that he had received "guarantees".

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

EDITORIAL. French pharmaceutical company Sanofi's plan to sell 50% of Opella, which produces France's favorite drug, to an ...

PARIS, Oct 14 (Reuters) - The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular Doliprane painkiller will stay in France to allow the ...